Skip to main content
Caplight Logo









Metaphore Biotechnologies

Metaphore Biotechnologies

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.metaphorebio.com/

Last Round

Early Funding

Apr 5, 2026

Total Funding Raised

$50M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Metaphore Biotechnologies is a biotechnology company that utilizes its proprietary MIMIC™ platform to design functional antibodies and therapeutic molecules based on biological dynamics and biomimicry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

computational drug discoveryAI drug discoverybiotech platformmolecular mimicryin silico drug designobesity therapeuticsmachine learning biologydrug discovery platformbiologicsmetabolic diseaseAI-native biotechcomputational biologytherapeutic designpharma partnershipprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Metaphore Biotechnologies Comparables

Compare Metaphore Biotechnologies with similar companies based on industry and business-model similarity.

Metaphore Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nabla Bio
84%
Valo Health
78%
Generate Biomedicines
77%

Metaphore Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 5, 2026
Series AMay 16, 2023

Key People

Founding team and executive leadership

Lovisa Afzelius

Co-founder Founding CEO

Founding Team

Metaphore Biotechnologies Investors

Notable investors and investment history

Metaphore Biotechnologies investors
InvestorRounds
Global Brain CorporationEarly Funding
Flagship PioneeringEarly Funding, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 5, 2026

    Raised capital from Flagship Pioneering and Novo Nordisk.

  • Oct 15, 2025

    $600M collaboration to develop obesity therapeutics.

Metaphore Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Metaphore Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Metaphore Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range53
Year Founded2021
Last FundingApr 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?